Literature DB >> 15722525

Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture.

Nobuyuki Kato1, Takashi Nakamura1, Hiromichi Dansako1, Katsuyuki Namba2, Ken-Ichi Abe1, Akito Nozaki1, Kazuhito Naka1, Masanori Ikeda1, Kunitada Shimotohno3.   

Abstract

Hepatitis C virus (HCV) genomic sequences are known to vary widely among HCV strains, but to date there have been few reports on the genetic variations and dynamics of HCV in an experimental system of HCV replication. In this study, a genetic analysis of HCV replicons obtained in long-term culture of two HCV replicon cells (50-1 and 1B-2R1), which were established from two HCV strains, 1B-1 and 1B-2, respectively, was performed. One person cultured 50-1 cells for 18 months, and two people independently cultured 50-1 cells for 12 months. 1B-2R1 cells were also cultured for 12 months. The whole nucleotide sequences of the three independent replicon RNA clones obtained at several time points were determined. It was observed that genetic mutations in both replicons accumulated in a time-dependent manner, and that the mutation rates of both replicons were approximately 3.0 x 10(-3) base substitutions/site/year. The genetic diversity of both replicons was also enlarged in a time-dependent manner. The colony formation assay by transfection of total RNAs isolated from both replicon cells at different time points into naive HuH-7 cells revealed that the genetic mutations accumulating with time in both replicons apparently improved colony formation efficiency. Taken together, these results suggest that the HCV replicon system is useful for the analysis of evolutionary dynamics and variations of HCV. Using this replicon cell culture system, it was demonstrated further that neither ribavirin nor its derivative mizoribine accelerated the mutation rate or the increase in the genetic diversity of HCV replicon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722525     DOI: 10.1099/vir.0.80479-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA.

Authors:  Gladys Gonzalez; Loretta Pfannes; Robert Brazas; Rob Striker
Journal:  J Virol Methods       Date:  2007-06-11       Impact factor: 2.014

2.  Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance.

Authors:  Megan H Powdrill; Egor P Tchesnokov; Robert A Kozak; Rodney S Russell; Ross Martin; Evguenia S Svarovskaia; Hongmei Mo; Roger D Kouyos; Matthias Götte
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-01       Impact factor: 11.205

3.  Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052.

Authors:  Chunfu Wang; Haichang Huang; Lourdes Valera; Jin-Hua Sun; Donald R O'Boyle; Peter T Nower; Lingling Jia; Dike Qiu; Xin Huang; Aneela Altaf; Min Gao; Robert A Fridell
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.938

4.  Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispecies.

Authors:  Dennis Revie; Michael O Alberti; Ravi S Braich; Nickolas Chelyapov; David Bayles; John G Prichard; S Zaki Salahuddin
Journal:  Virol J       Date:  2006-09-29       Impact factor: 4.099

5.  Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.

Authors:  Shinya Satoh; Kyoko Mori; Youki Ueda; Hiroe Sejima; Hiromichi Dansako; Masanori Ikeda; Nobuyuki Kato
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

6.  Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.

Authors:  John M Robida; Heather B Nelson; Zhe Liu; Hengli Tang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems.

Authors:  Nobuyuki Kato; Hiroe Sejima; Youki Ueda; Kyoko Mori; Shinya Satoh; Hiromichi Dansako; Masanori Ikeda
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

Review 8.  Modulation of host metabolism as a target of new antivirals.

Authors:  Masanori Ikeda; Nobuyuki Kato
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

9.  Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

Authors:  Anita Y M Howe; Huiming Cheng; Stephen Johann; Stanley Mullen; Srinivas K Chunduru; Dorothy C Young; Joel Bard; Rajiv Chopra; Girija Krishnamurthy; Tarek Mansour; John O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.